Skip to main content
Camurus logo

Camurus — Investor Relations & Filings

Ticker · CAMX ISIN · SE0007692850 LEI · 5493003S6Z6VI7WYFQ06 ST Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2026-04-29 Annual Report (ESEF)
Country SE Sweden
Listing ST CAMX

About Camurus

https://www.camurus.com/

Camurus is a science-led biopharmaceutical company that develops and commercializes innovative, long-acting medicines for severe and chronic diseases. The company specializes in advanced drug delivery systems designed to improve treatment outcomes, enhance patient quality of life, and provide value to society. Its therapeutic focus areas include opioid dependence, cancer and supportive care, endocrine conditions, rare diseases, and disorders of the central nervous system. Camurus maintains a diversified research and development pipeline to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-04-29 Swedish
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change Classification · 1% confidence The document is a press release titled “Förändring av antalet aktier och röster i Camurus,” describing the exercise of employee stock options under ESOP 2022/2026 which has increased the number of shares and votes outstanding. This is an announcement of a change in the company’s share capital structure (new shares issued upon option exercise). Under the FinancialReports taxonomy, such announcements of share issuance and capital changes fall under Share Issue/Capital Change (Code: SHA).
2026-03-31 Swedish
Change in number of shares and votes in Camurus
Share Issue/Capital Change Classification · 1% confidence The document is a press release disclosing the exercise of employee stock options under ESOP 2022/2026, resulting in a change in the total number of shares and votes. This is an announcement of a share issuance/capital change rather than an annual or interim report, earning release, or regulatory guideline. It directly concerns the company’s share capital structure. Therefore it fits the Share Issue/Capital Change category (SHA).
2026-03-31 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the company Camurus, covering the fourth quarter and the full year 2025. It contains detailed financial statements, management commentary on business performance, operational highlights, and future financial outlook. It is a comprehensive financial report for a period shorter than a full fiscal year (Q4) and the full year, fitting the definition of an Interim/Quarterly Report. Q4 2025
2026-02-12 Swedish
Earnings Release 2025
Earnings Release Classification · 1% confidence The document is a comprehensive financial report covering the fourth quarter and full year 2025 performance of Camurus. It includes detailed financial tables, management commentary on business and R&D pipeline progress, and future outlooks. It is not a short announcement (it exceeds 100,000 characters) and provides a full review of the period's financial results, making it an Interim/Quarterly Report (IR) rather than an Earnings Release (ER) or a Report Publication Announcement (RPA). Q4 2025
2026-02-12 English
Camurus ansökan om marknadsgodkännande av Oclaiz™ för behandling av akromegali accepterad för granskning av FDA
Regulatory Filings Classification · 1% confidence The document is a press release from Camurus announcing that the FDA has accepted their updated application for the drug Oclaiz for the treatment of acromegaly. It provides details on the PDUFA date, the nature of the drug, and the clinical program background. As this is a general regulatory announcement regarding company operations and product development that does not fit into specific financial reporting categories like 10-K or ER, it is classified as a Regulatory Filing (RNS).
2026-01-09 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.